Dendritic cell-targeting polymer nanoparticle-based immunotherapy for cancer: A review.

Hu, Yeye; Zhang, Wei; Chu, Xiaozhong; Wang, Aoran; He, Ziliang; Si, Chuan-Ling; Hu, Weicheng

Hu, Yeye; Zhang, Wei; Chu, Xiaozhong; Wang, Aoran; He, Ziliang; Si, Chuan-Ling; Hu, Weicheng.

Afiliação

Hu Y; Institute of Translational Medicine, School of Medicine, Yangzhou University, Yangzhou 225009, China; Tianjin Key Laboratory of Pulp & Paper, Tianjin University of Science & Technology, Tianjin 300457, China.
Zhang W; School of Life Sciences, Huaiyin Normal University, Huaian 223300, China.
Chu X; School of Chemistry & Chemical Engineering, Huaiyin Normal University, Huaian 223300, China.
Wang A; School of Chemistry & Chemical Engineering, Huaiyin Normal University, Huaian 223300, China.
He Z; School of Life Sciences, Huaiyin Normal University, Huaian 223300, China.
Si CL; Tianjin Key Laboratory of Pulp & Paper, Tianjin University of Science & Technology, Tianjin 300457, China. Electronic address: sichli@tust.edu.cn.
Hu W; Institute of Translational Medicine, School of Medicine, Yangzhou University, Yangzhou 225009, China; Affiliated Hospital of Yangzhou University, Yangzhou 225009, China; Jiangsu Key Laboratory of Experimental & Translational Non-Coding RNA Research, School of Medicine, Yangzhou University, Yangz

Int J Pharm ; 635: 122703, 2023 Mar 25.

Article em En | MEDLINE | ID: mdl-36758880

Assuntos

Nanopartículas; Neoplasias; Humanos; Células Dendríticas; Polímeros; Neoplasias/tratamento farmacológico; Imunoterapia

Palavras-chave

Dendritic cell; Immunity; Polymer; Receptor; Target

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nanopartículas / Neoplasias Limite: Humans Idioma: En Revista: Int J Pharm Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google